期刊文献+

Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma 被引量:7

Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma
原文传递
导出
摘要 Background Budd-Chiari syndrome (BCS) is characterized by liver sinusoidal congestion,ischemic liver cell damage,and liver portal hypertension caused by hepatic venous outflow constriction.The aim of this research was to investigate the clinicopathological features of BCS-associated hepatocellular carcinoma (HCC) and explore its surgical treatment and prognosis.Methods Clinical data from 38 patients with BCS-associated HCC who were surgically treated in our hospital from July 1998 to August 2010 were retrospectively analyzed.The clinicopathological features and prognosis of patients with BCS-associated HCC and surgical treatment for BCS-associated HCC were investigated.Results Compared to the patients with hepatitis B virus (HBV)-associated HCC,the patients with BCS-associated HCC showed a female predominance,and had significantly higher cirrhosis rate,higher incidence of solitary tumors,lower incidence of infiltrative growth,higher proportion of marginal or exogenous growth,lower rate of portal vein invasion,and higher degree of differentiation.Median survival was longer in patients with BCS-associated HCC (76 months) than in those with HBV associated HCC (38 months).Of 38 patients with BCS-associated HCC,22 patients who received combined surgery mainly by liver resection plus cavoatrial shunts exhibited hepatic venous outflow constriction relief,while the other 16 patients only underwent liver resection.The combined surgery group had significantly longer survival and lower incidences of post-operative lethal complications (P 〈0.05).Multivariate analysis showed that relief of hepatic venous outflow obstruction was a protective factor for survival of patients with BCS-associated HCC,whereas portal vein invasion was a risk factor.Conclusions BCS-associated HCC has a more favorable biological behavior and prognosis than HBV-associated HCC.For patients with BCS-associated HCC,tumor resection accompanied with relief of hepatic venous outflow obstruction can reduce the incidence of complications and extend survival. Background Budd-Chiari syndrome (BCS) is characterized by liver sinusoidal congestion,ischemic liver cell damage,and liver portal hypertension caused by hepatic venous outflow constriction.The aim of this research was to investigate the clinicopathological features of BCS-associated hepatocellular carcinoma (HCC) and explore its surgical treatment and prognosis.Methods Clinical data from 38 patients with BCS-associated HCC who were surgically treated in our hospital from July 1998 to August 2010 were retrospectively analyzed.The clinicopathological features and prognosis of patients with BCS-associated HCC and surgical treatment for BCS-associated HCC were investigated.Results Compared to the patients with hepatitis B virus (HBV)-associated HCC,the patients with BCS-associated HCC showed a female predominance,and had significantly higher cirrhosis rate,higher incidence of solitary tumors,lower incidence of infiltrative growth,higher proportion of marginal or exogenous growth,lower rate of portal vein invasion,and higher degree of differentiation.Median survival was longer in patients with BCS-associated HCC (76 months) than in those with HBV associated HCC (38 months).Of 38 patients with BCS-associated HCC,22 patients who received combined surgery mainly by liver resection plus cavoatrial shunts exhibited hepatic venous outflow constriction relief,while the other 16 patients only underwent liver resection.The combined surgery group had significantly longer survival and lower incidences of post-operative lethal complications (P 〈0.05).Multivariate analysis showed that relief of hepatic venous outflow obstruction was a protective factor for survival of patients with BCS-associated HCC,whereas portal vein invasion was a risk factor.Conclusions BCS-associated HCC has a more favorable biological behavior and prognosis than HBV-associated HCC.For patients with BCS-associated HCC,tumor resection accompanied with relief of hepatic venous outflow obstruction can reduce the incidence of complications and extend survival.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第19期3632-3638,共7页 中华医学杂志(英文版)
关键词 Budd-Chiari syndrome hepatocellular carcinoma surgical treatment PROGNOSIS Budd-Chiari syndrome hepatocellular carcinoma surgical treatment prognosis
  • 相关文献

参考文献2

二级参考文献25

  • 1Dhiman RK,Saraswat VA,Radhakrishnan S,Parashar A, Agarwal DK,Naik SR. Multiple venous thromboses and membranous obstruction of inferior vena cava in association with hereditary protein C deficiency: a case report. J Gastro- enterol Hepatol 1992; 7: 434-438.
  • 2Nakashima T,Okuda K,Kojiro M,Jimi A,Yamaguchi R, Sakamoto K,Ikari T. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Can- cer 1983; 51: 863-877.
  • 3Matsui S,Ichida T,Watanabe M,Sugitani S,Suda T,Taka- hashi T,Asakura H. Clinical features and etiology of hepa- tocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol 2000; 15: 1205-1211.
  • 4Tanaka M,Wanless IR. Pathology of the liver in Budd-Chi- ari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis,veno-portal cirrhosis,and large regen- erative nodules. Hepatology 1998; 27: 488-496.
  • 5Okuda K. Inferior vena cava thrombosis at its hepatic por- tion (obliterative hepatocavopathy). Semin Liver Dis 2002; 22: 15-26.
  • 6Gwon D,Ko GY,Yoon HK,Sung KB,Kim JH,Lee SS,Lee JM,Ohm JY,Shin JH,Song HY. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence,characteristics,and risk factors and clinical efficacy of TACE. Radiology 2010; 254: 617-626.
  • 7Moucari R,Rautou PE,Cazals-Hatem D,Geara A,Bureau C, Consigny Y,Francoz C,Denninger MH,Vilgrain V,Belghiti J,Durand F,Valla D,Plessier A. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008; 57: 828-835.
  • 8Eapen CE,Mammen T,Moses V,Shyamkumar NK. Chang- ing profile of Budd Chiari syndrome in India. Indian J Gastro- enterol 2007; 26: 77-81.
  • 9Kew MC,McKnight A,Hodkinson J,Bukofzer S,Esser JD. The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 1989; 9: 121-125.
  • 10Rector WG,Xu YH,Goldstein L,Peters RL,Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore) 1985; 64: 134-143.

共引文献24

同被引文献36

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部